Sapporo Clinical Laboratory Inc. operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sapporo Clinical Laboratory Inc. with three other
drug stores in Asia:
China Jo-Jo Drugstores Inc
sales of 818.53 million Chinese Renmimbi [US$120.19 million]
of which 63%
was Retail Drugstores),
(16.69 billion Japanese Yen [US$158.35 million]
of which 56%
was Pharmaceutical segment), and
Sunshine Holdings PLC
based in SRI LANKA
(20.83 billion Sri Lanka Rupees [US$112.70 million]
of which 54%
During the year ended March of 2020, sales at
Sapporo Clinical Laboratory Inc. were ¥17.66 billion (US$167.58 million).
increase of 3.5%
versus 2019, when the company's sales were ¥17.07 billion.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Sapporo Clinical Laboratory Inc. had sales
of ¥17.17 billion.